Serina Therapeutics Inc. (SER)
5.42
0.13 (2.46%)
At close: Mar 31, 2025, 3:58 PM
6.00
10.70%
After-hours: Mar 31, 2025, 05:45 PM EDT
Serina Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 3.67M | 345K | 532.23K | 314.85K | 527K | 2.35M | 6.71M | 7.38M | 259K |
| Short-Term Investments | n/a | n/a | n/a | 996.45K | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 10.6M | 50K | 50K | 50K | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | -50K | -50K | 1.59M | 2.26M | 2.73M | 1.91M | 2.34M |
| Receivables | n/a | n/a | n/a | 1.11K | 326K | 363K | 131K | 107K | 308K |
| Inventory | n/a | n/a | -1.79M | -1.61M | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2M | 352K | 16.35K | 17.85K | 1.43M | 1.34M | 1.01M | 111K | 121K |
| Total Current Assets | 5.68M | 754K | 548.58K | 1.33M | 2.28M | 4.05M | 7.85M | 7.59M | 688K |
| Property-Plant & Equipment | 1.05M | n/a | 309.47K | 514.15K | n/a | 1.13M | 90K | 129K | 195K |
| Goodwill & Intangibles | n/a | 607K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 1.05M | 11.21M | 309.47K | 514.15K | 1.64M | 3.39M | 2.82M | 2.04M | 2.54M |
| Total Assets | 6.72M | 11.96M | 858.04K | 1.84M | 3.92M | 7.44M | 10.67M | 9.63M | 3.22M |
| Account Payables | 744K | 580K | 143.34K | 145.47K | 761K | 420K | 150K | 75K | 261K |
| Deferred Revenue | n/a | n/a | 153.5K | n/a | 275K | 283K | 317K | 180K | 264K |
| Short-Term Debt | n/a | 3.67M | 128.4K | 211.79K | 2.4M | 428K | n/a | n/a | n/a |
| Other Current Liabilities | 1.62M | 1.66M | 12.45K | 14.21K | 1.93M | 2.17M | 1.97M | 1.06M | 25.07M |
| Total Current Liabilities | 2.37M | 5.91M | 437.69K | 371.47K | 5.36M | 3.3M | 2.44M | 1.31M | 25.6M |
| Long-Term Debt | 268K | 693K | 1.68M | 186.38K | 3.9M | 1.53M | n/a | n/a | n/a |
| Other Long-Term Liabilities | 3.58M | n/a | 36.52M | 36.39M | -1 | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 3.85M | 693K | 38.2M | 36.58M | 3.96M | 1.53M | n/a | n/a | n/a |
| Total Liabilities | 6.22M | 6.61M | 38.64M | 36.95M | 9.32M | 4.83M | 2.44M | 1.31M | 25.6M |
| Total Debt | 268K | 4.37M | 1.81M | 398.17K | 6.3M | 1.96M | n/a | n/a | n/a |
| Common Stock | 1K | n/a | 22.18K | 21.45K | 4K | 4K | 4K | 3K | 3K |
| Retained Earnings | -44.32M | -131.01M | -38.45M | -35.76M | -97.07M | -86.21M | -74.05M | -66.55M | -59.97M |
| Comprehensive Income | n/a | n/a | n/a | n/a | 143K | 69K | -2K | 68K | 58K |
| Shareholders Equity | 641K | 5.47M | -37.78M | -35.11M | -5.12M | 2.22M | 7.45M | 7.28M | -23.42M |
| Total Investments | n/a | 10.6M | 50K | 996.45K | 50K | n/a | n/a | n/a | n/a |